MHRA Chief Executive to step down
European Pharmaceutical Review
FEBRUARY 27, 2024
Her educational background includes training in medicine in Oxford after completing a master’s degree by research in Pharmacology. In 2012, Dame June was elected as the first chair of the European Pharmacovigilance Risk Assessment Committee, MHRA added.
Let's personalize your content